Table 13:
People at Low Surgical Risk Eligible to Receive TAVI in Ontario, 2019/20 to 2023/24
| Year | |||||
|---|---|---|---|---|---|
| Population | 2019/20 | 2020/21 | 2022/23 | 2023/24 | 2024/25 |
| SAVR, all indicationsa (n) | 3,086 | 3,143 | 3,199 | 3,255 | 3,311 |
| SAVR, aortic stenosisb (n) | 2,006 | 2,043 | 2,079 | 2,116 | 2,152 |
| SAVR, aortic stenosis and low surgical riskc (n) | 1,609 | 1,638 | 1,667 | 1,696 | 1,725 |
| SAVR patients eligible or likely to receive TAVId (n) | 1,126 | 1,146 | 1,167 | 1,187 | 1,208 |
Abbreviations: SAVR, surgical aortic valve replacement; TAVI, transcatheter aortic valve implantation.
a
Projected from total SAVR volumes from 2013/14 to 2018/19 in Ontario; see Table 1 in the Clinical Evidence section.
b
65% of SAVR in patients with aortic stenosis, based on previous analysis in Ontario (2012/13–2017/18) (written communication; Harindra Wijeysundera, MD, August 14, 2019).
c
80.18% of SAVR in patients at low surgical risk.8
d
70% of SAVR eligible for TAVI (assumption).